|
츮 ° , κ ȯڴ 鿪 ġ . ̴ ų ȭϰ 鿪 ڽſ ǿϱ 鿪 ġῡ ʰ Ƴ .
̹ T(鿪) ݷ پ CD8 T ȭϰ, ϼ ϴ 鿪 η δٴ Ըߴ. CD8 T 鿪ܹ PD-1, LAG-3 ٹ Ǹ鼭 ϼ ϴ ȭ ƴ. 鿪 ϰ ϴ M2 ļ 8 ̻ Ȯεƴ.
鿪 ϴ ܹ ϼ Ž 鿪 ϵ غŰ Ѵ. ̵ 㿡 41% ǰ, 56% ҵ Ȯߴ. Ư, 38% ٰ, ų CD8 T 2 , ϱ Ⱓ 2 þ. ȿ ð Ÿ Ⱓ ƴ.
ܵ ϸ پ 鿪 (PD-L1, COX2, IDO ) Ǵ ־ ȿ ϼ Ѵ. ش 10% ƿ Ұϴ.
̿ ϴ PD-1, COX2 鿪 ܹ ÿ ܵ ֵ PD-1 鿪 COX2 ϴ ҿ ۽(celecoxib) ϴ ߺġḦ ߴ. 40% ϼ , ߴ. Ư ü Ͽ ϴ 鿪 ϼ ٽ ص ϰ Ǵ Ȯεƴ.
å 系 츮 ſ 鿪 ִ 찡 3% Ұϸ, 97% ȯڿ 鿪 ġ ١ 鿪ġḦ ϰ ãƿ κ ȯڵ ۿ Ȳ̾. ̹ Ͽ 鿪 غ ִ ı ӻ ȴ١ Ǹ ߴ.
ܰ ߺ ӵ ϰ ִ ȯڸ žళ ƴ϶ ġᰡ Ұߴ ȯڵ鵵 ϴ ʰ ١ ̹ 鿪 ӻ ̾ ȯڵ鿡 ο DZ⸦ ٶ١ ߴ.
̹ бź ߰߿, óֱǷ , п(BRIC) ѱ (Ѻ) ƴ.
|
<۱ Ϻ (www.sudokwon.com) >